Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Clinical trial NCT00264459 · COMPLETED

Trial details

NCT number: NCT00264459
Sponsor: Allergopharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Grass Pollen Allergy

Start date: 2003-02-01
Primary completion: 2008-08-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.